Anti-arrhythmic agents

Author： Trybulski E.J.  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.7, Iss.5, 1997-05, pp. : 457-469

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Genetic polymorphisms relevant for anti-arrhythmic agents

By Dingermann Theo   Zündorf Ilse  

PHARMAKON, Vol. 1, Iss. 4, 2013-07 ,pp. : 344-349

Govi-Verlag

Access to resources Recommend Favorite

Pro- and Anti-Arrhythmic Effects of Anti-Inflammatory Drugs

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 12, Iss. 1, 2013-03 ,pp. : 83-93

Bentham Science Publishers

Access to resources Recommend Favorite

Utility of Anti-Arrhythmic Medications in ‘Lone Atrial Fibrillation’

By  

Current Pharmaceutical Design, Vol. 21, Iss. 5, 2015-02 ,pp. : 573-579

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-arrhythmic effects of levcromakalim in the ischaemic rat heart: a dual mechanism of action?

By Coetzee W.A.   Wells T.   Avkiran M.  

European Journal of Pharmacology, Vol. 402, Iss. 3, 2000-08 ,pp. : 263-274

Elsevier

Access to resources Recommend Favorite

Azimilide dihydrochloride: a new class III anti-arrhythmic agent

By Abrol R.   Page R.L.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 11, 2000-11 ,pp. : 2705-2715

Informa Healthcare

Access to resources Recommend Favorite